Lorianne Masuoka K. 4
4 · NEKTAR THERAPEUTICS · Filed Feb 3, 2010
Insider Transaction Report
Form 4
Lorianne Masuoka K.
SVP & Chief Medical Officer
Transactions
- Award
Stock Option
2010-02-01$11.34/sh+125,000$1,417,500→ 125,000 totalExercise: $11.34Exp: 2018-02-01→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The shares subject to this stock option shall vest on a monthly pro-rata basis over a period of four (4) years from the grant date (February 1, 2010).